A CLINICAL TRIAL COMPARING ORAL URACIL/FTORAFUR (UFT) [tegafur] PLUS LEUCOVORIN (LV) [folinic acid] WITH 5-FLUOROURACIL (5-FU) PLUS LV IN THE TREATMENT OF PATIENTS WITH STAGES II AND III CARCINOMA OF THE COLON.

Trial Profile

A CLINICAL TRIAL COMPARING ORAL URACIL/FTORAFUR (UFT) [tegafur] PLUS LEUCOVORIN (LV) [folinic acid] WITH 5-FLUOROURACIL (5-FU) PLUS LV IN THE TREATMENT OF PATIENTS WITH STAGES II AND III CARCINOMA OF THE COLON.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Oct 2014

At a glance

  • Drugs Tegafur/uracil (Primary) ; Fluorouracil; Folinic acid; Folinic acid
  • Indications Adenocarcinoma; Colorectal cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 19 Jan 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
    • 11 Apr 2007 Status change
    • 01 Feb 2007 QOL results published
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top